Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: READE SMITH who wrote (1620)	4/10/1999 12:04:00 PM
From: Jeff Chan	Read Replies (4) \| Respond to of 14101

If it goes lower, it goes lower... Yes, the waiting game can be a royal pain in the butt, however, there's not much that can be done until the word comes down from the US, Canada, or the UK authorities. It's an unusual opportunity to have a drug company with a regulatory approval pending that's so low in price. I can only suggest lack of coverage/knowledge by general public (due to lack of info) and also, possibly, the subject matter is not nearly as "sexy" as cancer, HIV, internet stocks, or whatever. In the last three months, the chart of DMX looks like it has formed what looks like a head and shoulders pattern...unless something happens, this is a bearish sign, since the next level of support is in the $2.80 range with a subsequent level of support in the $2.00ish range. Now, I'm certainly no technical analyst...I'd be interested to have comments from any chartists out there. Regards, Jeff C